Guangdong Hybribio Biotech Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 850.63 million compared to CNY 4,258.58 million a year ago. Revenue was CNY 850.63 million compared to CNY 4,258.58 million a year ago.

Net income was CNY 172.1 million compared to CNY 1,488.17 million a year ago. Basic earnings per share from continuing operations was CNY 0.2643 compared to CNY 2.271 a year ago. Diluted earnings per share from continuing operations was CNY 0.2643 compared to CNY 2.271 a year ago.